Literature DB >> 4009283

Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases.

O Geatti, B Shapiro, J C Sisson, R J Hutchinson, S Mallette, P Eyre, W H Beierwaltes.   

Abstract

Ten patients with histologically proven neuroblastoma were studied by [131I]MIBG scintigraphy. Tumor uptake of the radiopharmaceutical showed a spectrum varying from no uptake in one case, to slight uptake in two, moderate uptake in two and intense uptake in five cases. Iodine-131 MIBG scintigraphy was more effective in demonstrating the extent of neuroblastoma spread than were conventional bone scan and CT in one patient, equal to these modalities in four cases, almost equal in two cases and significantly inferior in three cases. These preliminary results suggest that [131I]MIBG scintigraphy is useful in detecting the presence and delineating the distribution of neuroblastoma and may, in certain cases, have therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4009283

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  14 in total

1.  Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.

Authors:  Arnoldo Piccardo; Egesta Lopci; Massimo Conte; Alberto Garaventa; Luca Foppiani; Vania Altrinetti; Cristina Nanni; Pietro Bianchi; Angela Cistaro; Stefania Sorrentino; Manlio Cabria; Andrea Pession; Matteo Puntoni; Giampiero Villavecchia; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-20       Impact factor: 9.236

Review 2.  Where are we with nuclear medicine in pediatrics?

Authors:  H R Nadel
Journal:  Eur J Nucl Med       Date:  1995-12

3.  A comparison of iodine-123 meta-iodobenzylguanidine scintigraphy and single bone marrow aspiration biopsy in the diagnosis and follow-up of 26 children with neuroblastoma.

Authors:  K Osmanagaoglu; M Lippens; Y Benoit; E Obrie; K Schelstraete; M Simons
Journal:  Eur J Nucl Med       Date:  1993-12

4.  Radionuclide therapy of malignant pheochromocytoma with 131I-MIBG.

Authors:  Y Nakabeppu; M Nakajo
Journal:  Ann Nucl Med       Date:  1994-11       Impact factor: 2.668

5.  The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.

Authors:  L Troncone; V Rufini; P Montemaggi; F M Danza; A Lasorella; R Mastrangelo
Journal:  Eur J Nucl Med       Date:  1990

6.  131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma.

Authors:  S Hibi; S Todo; S Imashuku; T Miyazaki
Journal:  Pediatr Radiol       Date:  1987

7.  123I metaiodobenzylguanidine (MIBG) scintigraphy of retinoblastoma: preliminary experience.

Authors:  J Bomanji; J L Hungerford; J E Kingston; D A Levison; K E Britton
Journal:  Br J Ophthalmol       Date:  1989-02       Impact factor: 4.638

8.  MIBG detection of hepatic neuroblastoma: correlation with CT, US and surgical findings.

Authors:  D A Dessner; M A DiPietro; B L Shulkin
Journal:  Pediatr Radiol       Date:  1993

9.  Utility of thallium-201 and iodine-123 metaiodobenzylguanidine in the scintigraphic detection of neuroendocrine neoplasia.

Authors:  F Montravers; G Coutris; L Sarda; B Mensch; J N Talbot
Journal:  Eur J Nucl Med       Date:  1993-11

10.  Metastatic neuroblastoma: new abnormalities on bone scintigraphy may not indicate tumour recurrence.

Authors:  M A Hall-Craggs; D Shaw; J Pritchard; I Gordon
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.